T A B L E O F C O N T E N T S B A C K G R O U N D

Description of the condition
Cervical myelopathy is a clinical condition of spinal cord dysfunction which demonstrates characteristic findings of upper motor neuron syndrome, also referred to as central motor neuron disease. One of the initial symptoms of myelopathy often involves loss of finger dexterity in the upper extremities. Patients usually report progressive loss of function including difficulty with fine movements in ordinary activities such as buttoning buttons and handwriting. Some patients also present with lower limb spasticity and a resultant wide based, shuffling gait. Ultimately, this ataxia may become so severe that patients become wheelchair dependent. In addition to ataxia, the lower limbs often demonstrate hyperreflexia and pathologic reflexes. These pathologic reflexes result from a pathway defect between peripheral nerves and the brain modulation, including Hoffmann's (thumb and index finger interphalangeal joints flex when distal phalanx of third finger is flicked), Babinsky's (extensor plantar reflex) and Openheimer's (dorsiflexion of the hallux elicited by stimulation of middle third of tibia) reflexes (Clarke 1956; Payne 1957; Tracy 2010; Veidlinger 1981) . The most common cause of cervical myelopathy is degenerative changes resulting in acquired stenosis. Cervical stenosis is a radiographic diagnosis based on the narrowing of the spinal canal, possibly leading to spinal cord compression and the clinical syndrome of cervical spondylotic myelopathy. The normal spinal canal diameter is 15 to 17mm, depending on measurement techniques and population. Patients with a cervical canal under 13mm of anterior to posterior diameter are considered to have stenosis (Chazono 2012; Edwards 1983) and progression of cervical myelopathy has been observed to occur in patients with midsagittal diameter less than 12mm (Boden 1990) . Axial sections demonstrating an area below 40mm 2 and compression ratio (relation between sagittal and transverse diameter) beneath 40% are also less favourable prognostic factors (Law 1993; Veidlinger 1981) . Degenerative changes, including hypertrophy of facet and uncovertebral joints (cartilage interface that connects adjacent vertebral bodies), osteophytosis (bone spurs), disc herniation, thickening of ligamentum flavum (ligaments that surround the posterior aspect of spinal cord) and ossification of posterior longitudinal ligament (structure related to anterior aspect of spinal cord), are the predominant structural changes that cause cervical stenosis (Bernhardt 1993; Edwards 2003) . Cervical spondylotic myelopathy can be classified by the syndromes it produces, divided into five categories:
1. Transverse lesion syndrome, where all spinal tracts are equally affected; 2. Motor system syndrome, where motor spinal tracts are involved, resulting in spasticity and loss of strength;
3. Central cord syndrome, where upper extremities are more severely affected than lower in sensory and motor aspects; 4. Brown-Séquard syndrome, where a patient presents ipsilateral motor deficits with contralateral sensory deficits; and 5. Braquialgia, where there is motor or sensory impairment in the upper extremity (Crandall 1966) . Cervical myelopathy also can be defined by the site in which compression occurs, separated into four syndromes:
1. Medial syndrome, with impairment primarily of long tract signs;
2. Lateral syndrome, characterized by radicular lesion; 3. Medial and lateral syndromes combined; and 4. Vascular syndrome, characterized by quickly progressive myelopathy signs due to vascular insufficiency (Ferguson 1985) 
Description of the intervention
Posterior surgical decompression procedures for cervical myelopathy are often used in patients with three or more levels involved. The most commonly performed approaches are laminectomy alone, laminectomy with arthrodesis, and laminoplasty (Highsmith 2011; Lee 2007; Manzano 2012) . Cervical laminectomy is the oldest procedure described for decompression of the cervical spinal cord. It has been applied since the early 1900s. It consists of removing posterior elements of the spinal canal including the lamina, spinal processes, interspinous and supraspinous ligaments, ligamentum flavum, and sometimes, portions of the articular facets (Jenkins 1973; Nurick 1972; Veidlinger 1981) . Cervical laminectomy is commonly performed along with fusion to prevent the development of post laminectomy kyphotic defor-mity. The most commonly performed fusion method is arthrodesis of the facet joints and lateral masses with lateral mass and pedicle screws. Nevertheless some spine surgeons choose not to use arthrodesis, but rather release the spinal cord using laminectomy alone or the skip laminectomy (a variation of classical laminectomy with less bone removed) (Heller 2001; Manzano 2012; Shiraishi 2003) . Cervical laminoplasty is a canal-expanding procedure to preserve motion in the cervical spine. Hirabayashi described the expansive open-door laminoplasty procedure in the late 1970s. The key principle of this procedure is to minimize disruption of the posterior structures of cervical spine including ligaments and muscular insertions, keeping them relatively preserved. By using a drill on both sides of the posterior vertebra, both the internal and external cortex of the lamina on one side is cut while only the external cortex is cut on the opposite site, and then the lamina is opened like a door (Hirabayashi 1978; Hirabayashi 1983) . A variation of Hirabayashi technique is called French-door or double-door laminoplasty (Kaneyama 2010; Kurokawa 1982; Okada 2009 ). This procedure is performed by making a cut in the centre of the spinal process and the external cortex on both sides of the lamina. Some surgeons use suture wire or bone grafts to keep the lamina or spinous process open. However, there are other options to maintain the decompression, such as small plates, anchors or similar devices (Lee 2007; Mitsunaga 2012).
How the intervention might work
Decompression of cervical spinal stenosis using a posterior approach, such as laminectomy or laminoplasty techniques, increases the space in the cervical canal. These procedures decompress the spinal cord directly by removing compressive posterior structures, and/or indirectly by increasing the transverse diameter of the cervical canal when compression is due to anterior structures (Herkowitz 2011).
Why it is important to do this review
Myelopathy secondary to spondylotic cervical canal stenosis is currently the most common cause of cervical spinal disease observed in patients over 55 years. The natural history of untreated cervical myelopathy is stepwise progression towards severe disability. As such, surgical decompression with or without fusion is the treatment of choice for patients with symptomatic cervical myelopathy (Bernhardt 1993; Edwards 2003; Fehlings 2013a; Fehlings 2013b; Lees 1963; Sampath 2000) . Posterior approaches such as laminectomy with bone fusion and laminoplasty are techniques most applied in patients with three or more compressive levels without kyphotic deformity. Laminectomy, as previously described, consists of removing vertebral lamina, spinal process, and ligaments to promote a wide decompres-sion. After decompression a rigid cervical fusion is performed with rods and screws. Laminoplasty also increases the cervical canal diameter but with less anatomical disruption. Additionally, cervical fusion is not performed. Since the spine is not fused and anatomical structures are preserved, it is argued that cervical spines after laminoplasty will maintain a greater range of motion when compared to cervical spines after laminectomy and fusion. Despite this theoretical advantage, clinically detectable differences between these two treatments have yet to be demonstrated (Bartels 2007; Hirabayashi 1983; Kaneyama 2010; Koakutsu 2010; Manzano 2012; Okada 2009; Shiraishi 2003; Woods 2011; Yukawa 2007) . The best surgical option for treating patients with multilevel cervical myelopathy remains a subject of great controversy. A recent survey of North American spine surgeons evaluated the most common surgical treatments employed for multilevel cervical spinal stenosis (three or more compressed levels), without kyphotic deformity, and with myelopathic symptoms. Findings indicate that laminectomy with fusion is the procedure of choice for 70% of surgeons, laminoplasty for 23%, and that just 7% of respondents chose laminectomy without fusion to treat this specific patient population (Manzano 2012). One of the major concerns of spine surgeons who perform multilevel cervical decompression is the development of postoperative cervical kyphosis (forward curvature). Cervical kyphosis may lead to a deterioration in neurological state due to compression of the spinal cord over the ventral kyphotic deformity. The normal cervical alignment averages 14.4 o of lordosis (Albert 1998). Cervical laminectomy without fusion has an incidence of postoperative kyphosis ranging from 14% to 47% (Anderson 2009; Kato 1998; Ryken 2009; van Geest 2013) . Rates of deterioration of neurological state associated with development of kyphosis can vary between 10% and 39% (Arnold 1993; Ebersold 1995; McAllister 2012; Yonenobu 1986) . It is still uncertain to what extent cervical spine instability with consequent kyphosis contributes to late neurological deterioration. These data may explain why cervical laminectomy without fusion is no longer a popular procedure. Laminectomy with fusion and laminoplasty seem to be the most commonly chosen procedures by spine surgeons due to safety and ethical concerns. This Cochrane systematic review will be conducted in order to identify randomized trials, quasi-randomized trials and non-randomized studies evaluating each procedure, and to clarify which is most beneficial to patients with cervical stenosis. In conclusion, since cervical myelopathy affects a considerable portion of the population and due to the lack of consensus regarding treatment, this review will help to elucidate the clinical nuances of the most commonly performed posterior approach procedures in order to achieve wide cervical decompression. If successful, this review can change the perspective of treatment of cervical myelopathy, increase patients' quality of life, and optimize costs, providing evidence-based data in order to assist spine surgeons to treat multilevel cervical myelopathy worldwide.
O B J E C T I V E S
The main objective of this review is to assess the effects of laminectomy and fusion versus laminoplasty for multilevel cervical stenosis with myelopathy, on treatment outcomes such as pain, quality of life, functional and neurological improvement, and complication rates.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomized controlled trials (RCTs) in this review. Moreover, since the preliminary search showed few RCTs on this topic, we will also include quasi-randomized controlled trials (q-RCTs) (i.e., non-random method of allocation such as hospital record number, date of care) as well as prospective observational studies with a control group, referred to here as non-randomized studies (NRSs).
Types of participants
Participants in included studies must meet the following criteria:
1. Older than 18 years; 2. Presence of symptomatic cervical myelopathy secondary to multilevel cervical canal stenosis (three or more levels of impairment); 3. Associated spondylosis, disc herniation, or ossification of the posterior longitudinal ligament (OPLL); 4. Magnetic resonance imaging (MRI) of cervical spinal cord compression. We will exclude studies involving participants who present with the following:
1. Any degree of kyphotic deformity on cervical spine; 2. Previous surgical intervention.
Types of interventions
We will include studies that compare laminectomy with fusion to laminoplasty, as these are the most commonly applied posterior approach procedures (Manzano 2012) for patients with multilevel cervical stenosis. We will also compare different laminoplasty surgeries such as single-door or double-door techniques as a secondary goal.
Studies that compare laminectomy without fusion to other interventions will be excluded.
Types of outcome measures
Primary and secondary outcomes may be measured at different time points. We define short-term follow-up as closest to four weeks and long-term follow-up as closest to one year (Furlan 2009). Outcomes related to neurological function, quality of life, pain, range of motion and reoperation rates may be measured at short-term and/or long-term follow-up. However we believe that long-term measurements will provide better indications of the patient's status after treatment, with the exception of nerve root palsy (usually a transitory symptom, C5 is the most commonly affected root), which is an important short-term outcome. Besides primary and secondary outcomes, major (e.g. mortality, irreversible paralysis, deep infection) and minor (e.g. superficial wound infection, dysphagia) adverse events also will be evaluated and included in the Discussion (Fehlings 2012).
Primary outcomes
• Measurements of neurological function based on a validated specific cervical scale:
• Japanese Orthopaedic Association (JOA) Scale (JOA 1976; JOA 1994) • Modified Japanese Orthopaedic Association (mJOA) Scale (Benzel 1991; Chiles 1999) • Neck Disability Index (Vernon 1991) • Nurick Scale (Nurick 1972) • Health related quality of life analysis will be measured through validated quality of life scales (e.g. Short-Form 36, JOA Cervical Myelopathy Evaluation Questionnaire/JOACEMQ, EuroQol) (Ware 1992 , Nikaido 2009 , EuroQol 1990 • Pain (visual analogue scale) (Revill 1976) • Cervical range of motion • Kyphosis incidence (the cervical sagittal alignment has been demonstrated to be an important outcome in spine surgery procedures. Previous studies demonstrated that laminectomy as well as laminoplasty techniques can be followed by the development of kyphotic deformity, a situation that can lead ultimately to an important deterioration of neurological status)
Secondary outcomes
• Nerve root palsy and recovery rates (most commonly affected is C5 nerve root)
• Reoperation rates
Search methods for identification of studies Electronic searches
We will search the following databases: No restrictions as to language or date of publication will be applied, and all databases will be searched from the date of their inception to present. We will use the search methods recommended by Furlan 2009 and Higgins 2011 and the strategies developed by the Cochrane Back Review Group (CBRG). A draft strategy for MEDLINE can be found in Appendix 1. It will be translated as closely as possible across the other databases. We will also search the following trial registries for ongoing studies: 
Searching other resources
Personal communication with experts in this field. We will also check reference lists of relevant review articles and trials.
Data collection and analysis
Selection of studies
Two authors (PHIP and TY) will analyse studies identified in the search. These authors will independently apply the inclusion criteria to select the potentially relevant studies by screening titles and abstracts as well as full texts. In case of disagreement, they will consult a third author (MJST) who will evaluate the full texts only.
Data extraction and management
All relevant data will be extracted independently by two authors (PHIP and MJST) and entered into a data sheet, in pairs, including information such as trial authors, affiliation, conflicts of interest, study design, number of patients, population characteristics, brief description of surgical techniques, follow-up periods, complications, reoperation data, outcome data, and a brief summary of risk of bias. The authors will enter all data into Review Manager 5.3 (RevMan 2014).
Assessment of risk of bias in included studies
Two authors, PHIP and MJST, will evaluate each study independently. Included studies will be assessed using the 'Risk of bias' criteria recommended by the CBRG (Furlan 2009; Higgins 2011) associated with items from the Downs and Black checklist (Downs 1998). In cases of disagreement, a third author (LMRR) will be consulted. These criteria are allocated into five bias categories, namely selection bias, performance bias, attrition bias, detection bias and selective outcome reporting, with a total of 13 distinct items (Appendix 2). We will evaluate the studies according the criteria mentioned above where each item will be scored according to its characteristics as 'high', 'low' or 'unclear' and reported in the 'Risk of bias' table. If one or more criteria are rated as 'unclear', we will contact the study authors for additional information. The overall risk of bias of each one of the five bias categories will be rated as 'bias' or 'no bias'. For grading the evidence quality we will assess studies as follows: the evidence level from studies that we qualified as 'no bias' for all five bias categories will not be downgraded. For studies that have three or fewer categories qualified as having 'bias', evidence will be downgraded by -1 point. Studies that have four or five categories qualified as having 'bias' will be downgraded by -2 points. We are aware of several potential confounders when examining treatment effects in this area. Some of them include age (patients less than 60 years old at the time of surgery have better neurological recovery), cervical curvature magnitude (normal preoperative cervical lordosis can be responsible for better outcome results), symptom duration (patients with longer symptomatology tend to have worse recovery), transverse area of spinal cord on MRI, etiology of cervical spinal stenosis (different populations susceptible to cervical spondylosis versus OPLL may have different outcomes), and differences related to follow-up outcome forms (Kohno 1997; Morio 2001; Naderi 1998; Tetreault 2013; Yamazaki 2003) .
Measures of treatment effect
We will calculate risk ratios (RRs) with a 95% confidence interval for dichotomous outcomes. However, for outcomes which are measured using different scales, we will report a standardized mean difference (SMD). For continuous outcomes we will calculate mean differences (MDs) comparing different studies with different weights according to the standard deviation (SD) also using a 95% confidence interval. When more than two interventions are present in same study, we will calculate a single 'pairwise' comparison to avoid 'double-counting' of patients.
Unit of analysis issues
The data of patients reported in included studies will be used as the unit of analysis.
Dealing with missing data
In studies where relevant data are missing, we will contact the authors of trials for additional information. Studies that have more than 20% of data missing will be subject to a sensitivity analysis to evaluate the impact of excluding these data from the analysis.
Assessment of heterogeneity
The I 2 statistic and Chi 2 test will be used to assess the clinically homogenous studies, while heterogenousstudies will be evaluated qualitatively. Then the review team will use clinical judgment to examine the potential sources of heterogeneity, such as differences in interventions, characteristics of participants, interventions, controls groups, and outcomes. If heterogeneity can be explained, we will present the results of each subgroup separately (Furlan 2009).
Assessment of reporting biases
To minimize the risk of publication bias, we will search trial registry databases for ongoing and unpublished trials. Duplicate publication bias is related to use of the same patients' data in multiple publications. To reduce the risk of bias, all such studies should be combined and analysed as a single study. Moreover to avoid language reporting bias, no limitations of language will be placed on the initial searches.
Data synthesis
If possible, the results will be pooled. We will calculate the risk ratios (RRs) with a 95% confidence interval for dichotomous outcomes. If included studies show clinical and methodological diversity, the random-effects model will be applied. The Chi 2 test will be used to assess heterogeneity with results inferior to 0.1 indicating significant statistical difference. If a meta-analysis is not possible, the results from clinically comparable trials will be described qualitatively in the text. Regardless of whether there are sufficient data available to use quantitative analysis to summarize the data, we will assess the overall quality of the evidence for each outcome. To accomplish this, we will use the GRADE approach, as recommended in the Cochrane Handbook for Systematic Reviews of interventions (Higgins 2011) and adapted in the updated CBRG method guidelines (Furlan 2009). Factors that may decrease the quality of the evidence are: study design and risk of bias, inconsistency of results, indirectness, imprecision (sparse data) and other factors (e.g. reporting bias). The quality of the evidence for a specific outcome will be reduced by a level, according to the performance of the studies against these five factors.
High quality evidence: there are consistent findings among at least 75% of RCTs with low risk of bias, consistent, direct and precise data and no known or suspected publication biases. Further research is unlikely to change either the estimate or our confidence in the results. Moderate quality evidence: one of the domains is not met. Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality evidence: two of the domains are not met. Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality evidence: three of the domains are not met. We are very uncertain about the results. No evidence: no RCTs were identified that addressed this outcome.
'Summary of findings' tables
The 'Summary of findings' tables will include the main comparison of this review, laminectomy and fusion versus laminoplasty. In order to assess the treatments we will report the following outcomes in each table: 1. Neurological function improvement; 2. Quality of life analysis; 3. Pain evaluation; 4. Cervical range of motion; 5. Kyphosis incidence; 6. C5 root palsy; 7. Reoperation rates.
Subgroup analysis and investigation of heterogeneity
We aim to perform subgroup analyses in order to explore heterogeneity due to the following factors: 1. Surgical technique applied, comparing different laminoplasty techniques 2. Patient characteristics:
• Physiopathology of cervical stenosis (development, degenerative, OPLL)
• Degree of neurological deficit • Levels affected • Age • Sagittal alignment before surgical procedure
Sensitivity analysis
A sensitivity analysis will be performed to investigate the effects of any important sources of bias. A glossary of relevant terms can be found in Appendix 3.
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Albert TJ, Vacarro A. Postlaminectomy kyphosis. Spine 1998;23(24): 2738-45. drawing of lots, minimization (minimization may be implemented without a random element, and this is considered to be equivalent to being random). There is a high risk of selection bias if the investigators describe a non-random component in the sequence generation process, such as: sequence generated by odd or even date of birth, date (or day) of admission, hospital or clinic record number; or allocation by judgement of the clinician, preference of the participant, results of a laboratory test or a series of tests, or availability of the intervention.
For non-randomized studies (NRSs) this will be rated as 'high bias' automatically.
Allocation concealment
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment
There is a low risk of selection bias if the participants and investigators enroling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomization); sequentially numbered drug containers of identical appearance; or sequentially numbered, opaque, sealed envelopes. There is a high risk of bias if participants or investigators enroling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; or other explicitly unconcealed procedures.
In cases of NRSs this will be rated as high bias.
Population* There is a low risk of bias if the participants included in different intervention groups are originating from the same population group.
Timing*
The risk of bias is considered low if the participants included in different intervention groups are recruited over the same time.
Adjustment for confounding*
There is a low risk of bias if there are no significant differences between the studied groups. Risk is considered high if there are no investigation or final analyses adjustment of the main confounders identified.
II. Performance bias
Blinding of participants
There is a low risk of performance bias if blinding of participants was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.
Blinding of personnel/care providers
There is a low risk of performance bias if blinding of personnel was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.
Compliance (adherence)
There is low risk of bias if compliance with the interventions was acceptable, based on the reported intensity/dosage, duration, number and frequency for both the index and control intervention(s). For single-session interventions (e.g. surgery), this item is irrelevant (van Tulder 2003).
Co-interventions
There is low risk of bias if there were no co-interventions or they were similar between the index and control groups (van Tulder 2003).
III. Attrition bias
Incomplete outcome data
There is a low risk of attrition bias if there were no missing outcome data; reasons for missing outcome data were unlikely to be related to the true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data were balanced in numbers, with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk was not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data, the plausible effect size (difference in means or standardized difference in means) among missing outcomes was not enough to have a clinically relevant impact on observed effect size, or missing data were imputed using appropriate methods (if dropouts are very large, imputation using even 'acceptable' methods may still suggest a high risk of bias) (van Tulder 2003). The percentage of withdrawals and drop-outs should not exceed 20% for short-term follow-up and 30% for long-term follow-up and should not lead to substantial bias (these percentages are commonly used but arbitrary, not supported by literature) (van Tulder 2003) .
Intention-to-treat analysis
There is low risk of bias if all randomized patients were reported/analyzed in the group to which they were allocated by randomization.
IV. Measurement/detection
Blinding of outcome assessment
There is low risk of bias if blinding of the outcome assessment was ensured and it was unlikely that the blinding could have been broken; or if no blinding of incomplete blinding was performed, but the review authors judge that the outcome is not likely to be influenced by lack of blinding, or:
• for participant-reported outcomes in which the participant was the outcome assessor (e.g. pain, disability): risk of bias for outcome assessors is low if risk of bias for participant blinding is low;
• for outcome criteria that are clinical or therapeutic events that will be determined by the interaction between participants and care providers (e.g. co-interventions, length of hospitalization, treatment failure), in which the care provider is the outcome assessor: risk of bias for outcome assessors is low if risk of bias for care providers is low;
• for outcome criteria that are assessed from data from medical forms: risk of bias is low if the treatment or adverse effects of the treatment could not be noticed in the extracted data.
Timing of outcome assessment
There is low risk of bias if all important outcome assessments for all intervention groups were measured at the same time (van Tulder 2003), or if analyses adjust for different lengths of follow-up.
V. Selective reporting
Data dredging
There is low risk of bias if all analyses were planned at the outset of the study, and high risk of bias if analyses were conducted retrospectively (e.g. retrospective unplanned subgroup analyses).
Outcome measures
There is low risk of reporting bias if the study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way, or if the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon). There is a high risk of reporting bias if not all of the study's pre-specified primary outcomes have been reported; one or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified; one or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a metaanalysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study. * Items are relevant to non-randomized studies exclusively.
